Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Southern Europe

Southern Europe

In Southern Europe, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$1.15bn.
It is projected to experience an annual growth rate of 2.00% from 2024 to 2029 (CAGR 2024-2029).
When compared globally, in China generates the highest revenue in this market, reaching US$4,408.00m in 2024.
In terms of per capita figures, each person in Southern Europe contributes US$4.84 to the revenue in 2024.
In Southern Europe, the demand for herbal digestive remedies is on the rise, as consumers increasingly seek natural alternatives for gastrointestinal health.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in Southern Europe is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in Southern Europe are increasingly seeking natural and herbal remedies for digestive issues. There is a growing preference for products that are made from natural ingredients and have minimal side effects. This shift in preference is driven by a greater awareness of the potential risks associated with synthetic drugs and a desire for more sustainable and environmentally friendly options. Additionally, customers are also looking for products that provide long-term relief and promote overall digestive health.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Southern Europe is the rising demand for probiotic supplements. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and improve digestion. Probiotic supplements are increasingly being used as a preventive measure to maintain a healthy gut and prevent digestive issues. This trend is driven by the growing understanding of the importance of gut health and the role of probiotics in maintaining it.Another trend in the market is the increasing popularity of traditional herbal remedies. Southern Europe has a rich tradition of herbal medicine, and there is a renewed interest in using traditional herbs for digestive health. Customers are turning to herbs like peppermint, ginger, and chamomile for their digestive benefits. These herbs are known for their soothing properties and can help alleviate symptoms such as bloating, indigestion, and stomach cramps.

Local special circumstances: Southern Europe has a Mediterranean diet, which is known for its emphasis on fresh fruits, vegetables, whole grains, and olive oil. This diet is considered to be beneficial for digestive health as it is rich in fiber and antioxidants. The Mediterranean diet also includes fermented foods like yogurt and kefir, which are natural sources of probiotics. The local dietary habits and cultural traditions contribute to the demand for Digestives & Intestinal Remedies in the region.

Underlying macroeconomic factors: The Digestives & Intestinal Remedies market in Southern Europe is also influenced by underlying macroeconomic factors. The region has a growing middle class with increasing disposable income, which allows customers to spend more on healthcare and wellness products. Additionally, the aging population in Southern Europe is driving the demand for digestive health products as older adults are more prone to digestive issues. The rising healthcare costs and the need for preventive measures are also contributing to the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in Southern Europe is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for natural and herbal remedies, probiotic supplements, and traditional herbal medicine is on the rise. The Mediterranean diet and cultural traditions also play a role in shaping customer preferences. The growing middle class, aging population, and increasing healthcare costs further contribute to the market growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.